If you've been diagnosed with moderately to severely active RA, REMICADE® may be able to help. In clinical trials, REMICADE®, when taken with methotrexate, has been shown to:
Individual results may vary.
As with any medication, it's important to keep your doctor informed about the impact of REMICADE® on your symptoms and about any side effects you may be having.
REMICADE® has been used to treat more than 1.3 million patients worldwide who have inflammatory conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, adult and pediatric Crohn's disease, ulcerative colitis, and ankylosing spondylitis.
REMICADE® is given as a 2-hour IV infusion by a healthcare professional, so someone is always there during your treatment, and for a period of time afterward, to monitor you for side effects. After the 3 starter doses, you may need REMICADE® only once every 8 weeks—as few as 6 times a year.
REMICADE®, like other medicines that affect your immune system, can cause serious side effects. Please read the Important Safety Information [1] and the Medication Guide [2] for REMICADE®, and discuss any questions or symptoms with your doctor.
Ask your rheumatologist if REMICADE® is right for you.
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking TNF-blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in teenage or young adult males with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase.
You should discuss any concerns about your health and medical care with your doctor.
What should I tell my doctor before I take REMICADE®?
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
What should I watch for and talk to my doctor about before or while taking REMICADE®?
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.
You should tell your doctor right away if you have any of the signs listed below:
For more information, please download the Full Prescribing Information and Medication Guide and discuss it with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Links:
[1] http://www.remicade.com/rheumatoid-arthritis/about-remicade#isi
[2] http://www.remicade.com/remicade/assets/med_guide.pdf
[3] http://www.remicade.com/rheumatoid-arthritis/how-remicade-works